These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 28040265)

  • 1. Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury.
    Oh CJ; Ha CM; Choi YK; Park S; Choe MS; Jeoung NH; Huh YH; Kim HJ; Kweon HS; Lee JM; Lee SJ; Jeon JH; Harris RA; Park KG; Lee IK
    Kidney Int; 2017 Apr; 91(4):880-895. PubMed ID: 28040265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity.
    Kim J; Long KE; Tang K; Padanilam BJ
    Kidney Int; 2012 Jul; 82(2):193-203. PubMed ID: 22437413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.
    Li S; Wu P; Yarlagadda P; Vadjunec NM; Proia AD; Harris RA; Portilla D
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F572-80. PubMed ID: 14612380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
    Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
    Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling Rho-kinase mediates inflammation and apoptosis in T cells and renal tubules in cisplatin nephrotoxicity.
    Nozaki Y; Kinoshita K; Hino S; Yano T; Niki K; Hirooka Y; Kishimoto K; Funauchi M; Matsumura I
    Am J Physiol Renal Physiol; 2015 Apr; 308(8):F899-909. PubMed ID: 25651561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing Oxidative Stress and Inflammation by Pyruvate Dehydrogenase Kinase 4 Inhibition Is Important in Prevention of Renal Ischemia-Reperfusion Injury in Diabetic Mice.
    Khang AR; Kim DH; Kim MJ; Oh CJ; Jeon JH; Choi SH; Lee IK
    Diabetes Metab J; 2024 May; 48(3):405-417. PubMed ID: 38311057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIGHT deficiency aggravates cisplatin-induced acute kidney injury by upregulating mitochondrial apoptosis.
    Yang Y; Meng L; Wu S; Li Y; Zhong Y; Xu F; Zhou XC; Li GQ; Xu GL; Peng KF
    Int Immunopharmacol; 2020 Dec; 89(Pt A):106999. PubMed ID: 33045563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-MCPD 1-Palmitate Induced Tubular Cell Apoptosis In Vivo via JNK/p53 Pathways.
    Liu M; Huang G; Wang TT; Sun X; Yu LL
    Toxicol Sci; 2016 May; 151(1):181-92. PubMed ID: 27008853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
    Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspase-11 promotes cisplatin-induced renal tubular apoptosis through a caspase-3-dependent pathway.
    Miao N; Wang B; Xu D; Wang Y; Gan X; Zhou L; Xue H; Zhang W; Wang X; Lu L
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F269-F279. PubMed ID: 28446458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of mitochondrial biogenesis through toll-like receptor 4-dependent mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling in endotoxin-induced acute kidney injury.
    Smith JA; Stallons LJ; Collier JB; Chavin KD; Schnellmann RG
    J Pharmacol Exp Ther; 2015 Feb; 352(2):346-57. PubMed ID: 25503387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy in proximal tubules protects against acute kidney injury.
    Jiang M; Wei Q; Dong G; Komatsu M; Su Y; Dong Z
    Kidney Int; 2012 Dec; 82(12):1271-83. PubMed ID: 22854643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intervention of mitochondrial activity attenuates cisplatin-induced acute kidney injury.
    Yang Y; Fu Y; Wang P; Liu S; Sha Y; Zhang Y; Zhang A; Jia Z; Ding G; Huang S
    Int Urol Nephrol; 2019 Jul; 51(7):1207-1218. PubMed ID: 31020626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
    Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
    Santos NA; Catão CS; Martins NM; Curti C; Bianchi ML; Santos AC
    Arch Toxicol; 2007 Jul; 81(7):495-504. PubMed ID: 17216432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and genetic inhibition of fatty acid-binding protein 4 alleviated cisplatin-induced acute kidney injury.
    Tan Z; Guo F; Huang Z; Xia Z; Liu J; Tao S; Li L; Feng Y; Du X; Ma L; Fu P
    J Cell Mol Med; 2019 Sep; 23(9):6260-6270. PubMed ID: 31286669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde dehydrogenase 2 alleviates mitochondrial dysfunction by promoting PGC-1α-mediated biogenesis in acute kidney injury.
    Li J; Shi X; Chen Z; Xu J; Zhao R; Liu Y; Wen Y; Chen L
    Cell Death Dis; 2023 Jan; 14(1):45. PubMed ID: 36670098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo.
    Terada Y; Inoue K; Matsumoto T; Ishihara M; Hamada K; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Horino T; Karashima T; Tamura K; Fukuhara H; Fujimoto S; Tsuda M; Shuin T
    PLoS One; 2013; 8(12):e80850. PubMed ID: 24324635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.
    Li S; Basnakian A; Bhatt R; Megyesi J; Gokden N; Shah SV; Portilla D
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F990-8. PubMed ID: 15280156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.